Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence

BackgroundHepatocellular carcinoma (HCC) recurrence after liver transplantation is frequently multiple and extrahepatic, and with a poor prognosis. The therapeutic effects of current medications for post-transplant HCC recurrence are limited. This study assessed whether outcomes could be improved by...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei-Chen Lee, Chih-Hsien Cheng, Tsung-Han Wu, Yu-Chao Wang, Jin-Chiao Lee, Hao-Chien Hung, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
DC
dendritic cell
hepatocellular carcinoma
liver transplantation
tyrosine kinase inhibitor
immune checkpoint inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589634/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589634/full

Similar Items